Neoantigen Cancer Vaccine Market Size, Share & Trends Analysis Report By Product (Personalized and Off-The-Shelf Neoantigen Vaccines), By Neovaccine Type, By Therapeutic Area, By Therapy Type, Region And Segment Forecasts, 2025-2034

Report Id: 1117 Pages: 180 Last Updated: 22 May 2025 Format: PDF / PPT / Excel / Power BI
Share With : linkedin twitter facebook

Global Neoantigen Cancer Vaccine Market is expected to grow at a 20.0% CAGR during the forecast period for 2025-2034.

Neoantigen Cancer Vaccines are vaccines that assist in boosting the immune system by using a single or several antigens. The antigens generally consist of several peptides or proteins. Neoantigens are a mutated or a new type of antigen present only in cancer cells and not in rest normal cells. Neoantigen Cancer Vaccines stimulate the new T-cell response against the mutated antigens present in the cancer cells.

Neoantigen Cancer Vaccine Market  

Neoantigen Cancer Vaccine has recorded with proven effectiveness and satisfactory results in clinical trials test of cancer treatment. Increasing cases for cancer patients across the globe and rising focus on specific & effective cancer management treatments are propelling the demand for oncology drugs and apparently boosting the market for global Neoantigen Cancer Vaccine market. Increasing emphasis on personalized cancer treatment and rising economic burden due to cancer treatment procedures has led the pharmaceutical manufacturers to invest significantly in research and development activities in order to fulfil the existing as well as latent demand for Neoantigen Cancer Vaccine.

Market Segmentation

The neoantigen cancer vaccines market is segmented on the basis of product, neovaccine type, therapy type, and region. Based on the products, the market is divided into Personalized neoantigens vaccines and Off-the-shelf Neoantigen vaccines. On the basis of neovaccine type, the market is segmented into Nucleic acid/DNA/mRNA Vaccine, Peptide Vaccines, and Dendritic Cell-based Vaccines. Based on region, the market is studied across North America, Asia-Pacific, Europe, and the Rest of World. North America is expected to dominate the market during the analysis of the forecast period.

Competitive Landscape

Some of The Key Players in The Neoantigen Cancer Vaccine Market:

  • Roche
  • Medimmune
  • Moderna Therapeutics/Merck
  • Advaxis
  • Agenus
  • Genocea Biosciences Inc
  • Gritstone Oncology
  • Neon Therapeutics
  • Nouscom
  • OSE Immunotherapeutics
  • Immunovative Therapeutics
  • Medigene
  • Vaccibody
  • Brightpath Biotherapeutics
  • Geneos Therapeutics
  • Frame Therapeutics
  • Immunetune
  • NeoPhore
  • CureVac AG
  • Other Prominent Players

The Neoantigen Cancer Vaccine Market Report Scope

Report Attribute Specifications
Growth Rate CAGR CAGR of 20.0% from 2025 to 2034
Quantitative Units Representation of revenue in US$ Mn,and CAGR from 2025 to 2034
Historic Year 2021 to 2024
Forecast Year 2025-2034
Report Coverage The forecast of revenue, the position of the company, the competitive market structure, growth prospects, and trends
Segments Covered By Product, By Neovaccine Type, By Therapeutic Area By Therapy Type
Regional Scope North America; Europe; Asia Pacific; Latin America; Middle East & Africa
Country Scope U.S.; Canada; U.K.; Germany; China; India; Japan; Brazil; Mexico; The UK; France; Italy; Spain; China; Japan; India; South Korea; South East Asia; South Korea; South East Asia
Competitive Landscape Moderna Therapeutics/Merck, Advaxis, Agenus, Genocea Biosciences Inc, Gritstone Oncology, Neon Therapeutics, Nouscom, OSE Immunotherapeutics, Immunovative Therapeutics, Medigene, Vaccibody, Brightpath Biotherapeutics, Geneos Therapeutics, Frame Therapeutics, Immunetune, NeoPhore, and CureVac AG., and Others
Customization Scope Free customization report with the procurement of the report, Modifications to the regional and segment scope. Particular Geographic competitive landscape.
Pricing and Available Payment Methods Explore pricing alternatives that are customized to your particular study requirements.

Global Neoantigen Cancer Vaccine Market Segmentation

Global Neoantigen Cancer Vaccine Market by Product

  • Personalized Neoantigens vaccines
  • Off-the-shelf Neoantigen vaccines

Neoantigen Cancer Vaccine Market

Global Neoantigen Cancer Vaccine Market Based on Neovaccine Type

  • Nucleic acid/DNA/mRNA Vaccine
  • Peptide Vaccines
  • Dendritic Cell–based Vaccines

Global Neoantigen Cancer Vaccine Market Based on Therapy Type

  • Mono Therapeutic Regimens
  • Combinatorial Regimens

Global Neoantigen Cancer Vaccine Market Based on Region

Europe Neoantigen Cancer Vaccine Market Outlook, 

  • U.K.
  • Germany
  • France
  • Italy
  • Spain
  • Russia
  • Rest of Europe

North America Neoantigen Cancer Vaccine Market Outlook,

  • U.S.
  • Canada

Asia Pacific Neoantigen Cancer Vaccine Market Outlook,

  • China
  • Japan
  • South Korea
  • Australia & New Zealand

Need specific information/chapter from the report of the custom data table, graph or complete report? Tell us more.

Research Design and Approach

This study employed a multi-step, mixed-method research approach that integrates:

  • Secondary research
  • Primary research
  • Data triangulation
  • Hybrid top-down and bottom-up modelling
  • Forecasting and scenario analysis

This approach ensures a balanced and validated understanding of both macro- and micro-level market factors influencing the market.

Secondary Research

Secondary research for this study involved the collection, review, and analysis of publicly available and paid data sources to build the initial fact base, understand historical market behaviour, identify data gaps, and refine the hypotheses for primary research.

Sources Consulted

Secondary data for the market study was gathered from multiple credible sources, including:

  • Government databases, regulatory bodies, and public institutions
  • International organizations (WHO, OECD, IMF, World Bank, etc.)
  • Commercial and paid databases
  • Industry associations, trade publications, and technical journals
  • Company annual reports, investor presentations, press releases, and SEC filings
  • Academic research papers, patents, and scientific literature
  • Previous market research publications and syndicated reports

These sources were used to compile historical data, market volumes/prices, industry trends, technological developments, and competitive insights.

Secondary Research

Primary Research

Primary research was conducted to validate secondary data, understand real-time market dynamics, capture price points and adoption trends, and verify the assumptions used in the market modelling.

Stakeholders Interviewed

Primary interviews for this study involved:

  • Manufacturers and suppliers in the market value chain
  • Distributors, channel partners, and integrators
  • End-users / customers (e.g., hospitals, labs, enterprises, consumers, etc., depending on the market)
  • Industry experts, technology specialists, consultants, and regulatory professionals
  • Senior executives (CEOs, CTOs, VPs, Directors) and product managers

Interview Process

Interviews were conducted via:

  • Structured and semi-structured questionnaires
  • Telephonic and video interactions
  • Email correspondences
  • Expert consultation sessions

Primary insights were incorporated into demand modelling, pricing analysis, technology evaluation, and market share estimation.

Data Processing, Normalization, and Validation

All collected data were processed and normalized to ensure consistency and comparability across regions and time frames.

The data validation process included:

  • Standardization of units (currency conversions, volume units, inflation adjustments)
  • Cross-verification of data points across multiple secondary sources
  • Normalization of inconsistent datasets
  • Identification and resolution of data gaps
  • Outlier detection and removal through algorithmic and manual checks
  • Plausibility and coherence checks across segments and geographies

This ensured that the dataset used for modelling was clean, robust, and reliable.

Market Size Estimation and Data Triangulation

Bottom-Up Approach

The bottom-up approach involved aggregating segment-level data, such as:

  • Company revenues
  • Product-level sales
  • Installed base/usage volumes
  • Adoption and penetration rates
  • Pricing analysis

This method was primarily used when detailed micro-level market data were available.

Bottom Up Approach

Top-Down Approach

The top-down approach used macro-level indicators:

  • Parent market benchmarks
  • Global/regional industry trends
  • Economic indicators (GDP, demographics, spending patterns)
  • Penetration and usage ratios

This approach was used for segments where granular data were limited or inconsistent.

Hybrid Triangulation Approach

To ensure accuracy, a triangulated hybrid model was used. This included:

  • Reconciling top-down and bottom-up estimates
  • Cross-checking revenues, volumes, and pricing assumptions
  • Incorporating expert insights to validate segment splits and adoption rates

This multi-angle validation yielded the final market size.

Forecasting Framework and Scenario Modelling

Market forecasts were developed using a combination of time-series modelling, adoption curve analysis, and driver-based forecasting tools.

Forecasting Methods

  • Time-series modelling
  • S-curve and diffusion models (for emerging technologies)
  • Driver-based forecasting (GDP, disposable income, adoption rates, regulatory changes)
  • Price elasticity models
  • Market maturity and lifecycle-based projections

Scenario Analysis

Given inherent uncertainties, three scenarios were constructed:

  • Base-Case Scenario: Expected trajectory under current conditions
  • Optimistic Scenario: High adoption, favourable regulation, strong economic tailwinds
  • Conservative Scenario: Slow adoption, regulatory delays, economic constraints

Sensitivity testing was conducted on key variables, including pricing, demand elasticity, and regional adoption.

Name field cannot be blank!
Email field cannot be blank!(Use email format)
Designation field cannot be blank!
Company field cannot be blank!
Contact No field cannot be blank!
Message field cannot be blank!
8362
Security Code field cannot be blank!

Frequently Asked Questions

Global Neoantigen Cancer Vaccine Market is expected to grow at a 20.0% CAGR during the forecast period for 2025-2034.

Moderna Therapeutics/Merck, Advaxis, Agenus, Genocea Biosciences Inc, Gritstone Oncology, Neon Therapeutics, Nouscom, OSE Immunotherapeutics, Immunova

Product, Neovaccine Type, Therapeutic Area and Therapy Type are the key segments of the Neoantigen Cancer Vaccine Market.

North American region is leading the Neoantigen Cancer Vaccine Market.
Get Sample Report Enquiry Before Buying